Clinical characteristics and outcomes of critically ill patients with COVID-19 in a tertiary community hospital in upstate New York
Background: There are limited reports describing critically ill COVID-19 patients in the state of New York. Methods: We conducted a retrospective analysis of 32 adult critically ill patients admitted to a community hospital in upstate New York, between 14 March and 12 April 2020. We collected demogr...
Na minha lista:
Main Authors: | , , , , , , |
---|---|
Formato: | Livro |
Publicado em: |
Greater Baltimore Medical Center,
2020-11-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_a65123f6e1d94ce1960538045897b13a | ||
042 | |a dc | ||
100 | 1 | 0 | |a Jyotirmayee Lenka |e author |
700 | 1 | 0 | |a Mamta S. Chhabria |e author |
700 | 1 | 0 | |a Naman Sharma |e author |
700 | 1 | 0 | |a Bryan E-Xin Tan |e author |
700 | 1 | 0 | |a Leela Krishna Teja Boppana |e author |
700 | 1 | 0 | |a Sharini Venugopal |e author |
700 | 1 | 0 | |a Damanpaul S. Sondhi |e author |
245 | 0 | 0 | |a Clinical characteristics and outcomes of critically ill patients with COVID-19 in a tertiary community hospital in upstate New York |
260 | |b Greater Baltimore Medical Center, |c 2020-11-01T00:00:00Z. | ||
500 | |a 2000-9666 | ||
500 | |a 10.1080/20009666.2020.1811070 | ||
520 | |a Background: There are limited reports describing critically ill COVID-19 patients in the state of New York. Methods: We conducted a retrospective analysis of 32 adult critically ill patients admitted to a community hospital in upstate New York, between 14 March and 12 April 2020. We collected demographic, laboratory, ventilator and treatment data, which were analyzed and clinical outcomes tabulated. Results: 32 patients admitted to the intensive care unit (ICU) were included, with mean (±SD) follow-up duration 21 ± 7 days. Mean (±SD) age was 62.2 ± 11.2 years, and 62.5% were men. 27 (84.4%) of patients had one or more medical co-morbidities. The mean (±SD) duration of symptoms was 6.6 (±4.4) days before presentation, with cough (81.3%), dyspnea (68.7%), and fever (65.6%) being the most common. 23 (71.9%) patients received invasive mechanical ventilation. 5 (15.6%) died, 11 (34.4%) were discharged home, and 16 (50%) remained hospitalized, 8 (25%) of which were still in ICU. Mean (±SD) length of ICU stay was 10.2 (±7.7) days, and mean (±SD) length of hospital stay was 14.8 (±7.7) days. Conclusion: Majority of patients were of older age and with medical comorbidities. With adequate resource utilization, mortality of critically ill COVID-19 patients may not be as high as previously suggested. Abbreviations: ACE-i: Angiotensin converting enzyme inhibitor; ARB: Angiotensin receptor blocker; ARDS: Acute Respiratory Distress Syndrome; BiPAP: Bilevel positive airway pressure; CABG: Coronary artery bypass graft; CFR: Case fatality rate; COVID-19: Coronavirus disease 19; CPAP: Continuous positive airway pressure; CRP: C - Reactive Protein; CT: Computed tomography; DVT: Deep vein thrombosis; ECMO: Extra Corporeal Membrane Oxygenation; ESICM: European Society of Intensive Care Medicine; FiO2: Fraction of inspired O2; HFNC: High Flow Nasal Cannula; HITF: Hypoxia-Inducible Transcription Factor; IBM: International Business Machines; ICU: Intensive Care Unit; IL: Interleukin; IMV: Invasive Mechanical Ventilation; IQR: Interquartile Range; ISTH: International Society of Thrombosis Hemostasis; NIV: Non Invasive Ventilation; NY: New York; PAI: Plasminogen activator inhibitor; PaO2: partial pressure of arterial oxygen; PCV: Pressure Control Ventilation; PEEP: Positive End Expiratory Pressure; RGH: Rochester General Hospital; RRH: Rochester Regional Health; RT-PCR: Reverse transcriptase polymerase chain reaction; RSV: Respiratory Syncytial virus; SARS-CoV-2: Severe Acute Respiratory Syndrome Coronavirus 2; SD: Standard Deviation; STEMI: ST segment elevation myocardial infarction; TNF: Tumor necrosis factor; USA: USA; VTE: Venous thromboembolism | ||
546 | |a EN | ||
690 | |a sars-cov-2 | ||
690 | |a covid-19 | ||
690 | |a icu | ||
690 | |a ventilator | ||
690 | |a new york | ||
690 | |a Internal medicine | ||
690 | |a RC31-1245 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Journal of Community Hospital Internal Medicine Perspectives, Vol 10, Iss 6, Pp 491-500 (2020) | |
787 | 0 | |n http://dx.doi.org/10.1080/20009666.2020.1811070 | |
787 | 0 | |n https://doaj.org/toc/2000-9666 | |
856 | 4 | 1 | |u https://doaj.org/article/a65123f6e1d94ce1960538045897b13a |z Connect to this object online. |